CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV and HCV), performed on the Tigris testing platform, to the -enhanced Ultrio Elite triplex assay performed on the Panther testing platform on July 13, 2020. The implementation date has been moved up to July 7th. Contact your Customer Service Manager if you have any questions!
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...
Daylight Saving Time Begins March 10, 2019. As a friendly reminder, airlines often change their rout...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...